These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 16627050)

  • 1. Reducing infarct size in the setting of acute myocardial infarction.
    Downey JM; Cohen MV
    Prog Cardiovasc Dis; 2006; 48(5):363-71. PubMed ID: 16627050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Realizing the clinical potential of ischemic preconditioning and postconditioning.
    Yellon DM; Hausenloy DJ
    Nat Clin Pract Cardiovasc Med; 2005 Nov; 2(11):568-75. PubMed ID: 16258568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Reperfusion and postconditioning in acute ST segment elevation myocardial infarction. A new paradigm for the treatment of acute myocardial infarction. From bench to bedside?].
    Lupi Herrera E; Gaspar J; González Pacheco H; Martínez Sánchez C; Pastelín Hernández G; Luna Ortiz P; Chávez Cosio E
    Arch Cardiol Mex; 2006; 76 Suppl 4():S76-101. PubMed ID: 17469337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning.
    Ferdinandy P; Schulz R; Baxter GF
    Pharmacol Rev; 2007 Dec; 59(4):418-58. PubMed ID: 18048761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial preconditioning in humans.
    Tzivoni D
    Isr Med Assoc J; 2000 May; 2(5):393-6. PubMed ID: 10892398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preconditioning, postconditioning and their application to clinical cardiology.
    Kloner RA; Rezkalla SH
    Cardiovasc Res; 2006 May; 70(2):297-307. PubMed ID: 16516180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mapping preconditioning's signaling pathways: an engineering approach.
    Downey JM; Krieg T; Cohen MV
    Ann N Y Acad Sci; 2008 Mar; 1123():187-96. PubMed ID: 18375591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preconditioning and postconditioning: united at reperfusion.
    Hausenloy DJ; Yellon DM
    Pharmacol Ther; 2007 Nov; 116(2):173-91. PubMed ID: 17681609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cardioprotective effect of remote ischemic preconditioning].
    Maslov LN; Lishmanov IuB
    Angiol Sosud Khir; 2009; 15(3):141-51. PubMed ID: 20092197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardioprotective properties of humoral factors released from rat hearts subject to ischemic preconditioning.
    Serejo FC; Rodrigues LF; da Silva Tavares KC; de Carvalho AC; Nascimento JH
    J Cardiovasc Pharmacol; 2007 Apr; 49(4):214-20. PubMed ID: 17438406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ischemic but not mechanical preconditioning attenuates ischemia/reperfusion induced myocardial apoptosis in anaesthetized rabbits: the role of Bcl-2 family proteins and ERK1/2.
    Lazou A; Iliodromitis EK; Cieslak D; Voskarides K; Mousikos S; Bofilis E; Kremastinos DT
    Apoptosis; 2006 Dec; 11(12):2195-204. PubMed ID: 17051325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of kappa-opioid receptors at reperfusion affords cardioprotection in both rat and mouse hearts.
    Peart JN; Gross ER; Reichelt ME; Hsu A; Headrick JP; Gross GJ
    Basic Res Cardiol; 2008 Sep; 103(5):454-63. PubMed ID: 18500486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preconditioning and postconditioning: new strategies for cardioprotection.
    Hausenloy DJ; Yellon DM
    Diabetes Obes Metab; 2008 Jun; 10(6):451-9. PubMed ID: 17825079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinically useful cardioprotection: ischemic preconditioning then and now.
    Vander Heide R
    J Cardiovasc Pharmacol Ther; 2011; 16(3-4):251-4. PubMed ID: 21821524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transient metabolic alkalosis during early reperfusion abolishes helium preconditioning against myocardial infarction: restoration of cardioprotection by cyclosporin A in rabbits.
    Pagel PS; Krolikowski JG
    Anesth Analg; 2009 Apr; 108(4):1076-82. PubMed ID: 19299764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The production of hydrogen sulfide limits myocardial ischemia and reperfusion injury and contributes to the cardioprotective effects of preconditioning with endotoxin, but not ischemia in the rat.
    Sivarajah A; McDonald MC; Thiemermann C
    Shock; 2006 Aug; 26(2):154-61. PubMed ID: 16878023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of xenon anesthesia on the size of experimental myocardial infarction.
    Baumert JH; Hein M; Gerets C; Baltus T; Hecker KE; Rossaint R
    Anesth Analg; 2007 Nov; 105(5):1200-6, table of contents. PubMed ID: 17959941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physiology and pharmacology of myocardial preconditioning and postconditioning.
    Huffmyer J; Raphael J
    Semin Cardiothorac Vasc Anesth; 2009 Mar; 13(1):5-18. PubMed ID: 19329471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Limitation of myocardial infarct size in the clinical setting: current status and challenges in translating animal experiments into clinical therapy.
    Miura T; Miki T
    Basic Res Cardiol; 2008 Nov; 103(6):501-13. PubMed ID: 18716709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ischemic preconditioning modulates mitochondrial respiration, irrespective of the employed signal transduction pathway.
    Liem DA; Manintveld OC; Schoonderwoerd K; McFalls EO; Heinen A; Verdouw PD; Sluiter W; Duncker DJ
    Transl Res; 2008 Jan; 151(1):17-26. PubMed ID: 18061124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.